| Patricia Kay Jolley, | |
|
700 Campbell St, Baker City, OR 97814-2212 | |
| (541) 523-0607 | |
| (541) 523-0589 |
| Full Name | Patricia Kay Jolley |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 700 Campbell St, Baker City, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790058428 | NPI | - | NPPES |
| PH 00019693 | Other | WA | STATE PHARMACIST LICENSE |
| RPH-0006801 | Other | OR | STATE PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH 00019693 (Washington) | Secondary |
| 183500000X | Pharmacist | RPH-0006801 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Kay Jolley, 700 Campbell St, Baker City, OR 97814-2212 Ph: (541) 523-0607 | Patricia Kay Jolley, 700 Campbell St, Baker City, OR 97814-2212 Ph: (541) 523-0607 |
News Archive
PLx Pharma Inc, a Houston-based pharmaceutical company developing a medical discovery made at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded $565,449 for the first year of a potential two-year $1,118,398 grant to conduct research designed to enhance a treatment for premature babies with a common congenital heart defect.
Under the most recent cost-saving budget proposals, 327 adult day healthcare centers throughout California would be eliminated. Cuts could save the state $135 million in fiscal 2011, state projections show.
Multidrug resistant bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) pose a major problem for patients, doctors, and the pharmaceutical industry. To combat such bacteria, it is critical to understand how resistance is developed in the first place. It is commonly thought that an incomplete course of antibiotics would lead to resistance to that particular antibiotic by allowing the bacteria to make adaptive changes under less stringent conditions.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets.
Research from Karolinska Institutet in Sweden shows that the human olfactory bulb - a structure in the brain that processes sensory input from the nose - differs from that of other mammals in that no new neurons are formed in this area after birth. The discovery, which is published in the scientific journal Neuron, is based on the age-determination of the cells using the carbon-14 method, and might explain why the human sense of smell is normally much worse than that of other animals.
› Verified 1 days ago
Michelle L Budd, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1120 Campbell St, Baker City, OR 97814 Phone: 541-524-0416 | |
Janet Plumley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1205 Campbell St, Baker City, OR 97814 Phone: 541-523-6743 Fax: 541-523-7253 | |
Mr. Jeffrey Aaron Aster, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1120 Campbell St, Baker City, OR 97814 Phone: 541-524-0416 | |
Marilyn Lois Anderson-labeau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1205 Campbell St, Baker City, OR 97814 Phone: 541-523-6743 | |
Lana Foster, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1217 Campbell St, Baker City, OR 97814 Phone: 541-523-2138 | |
Christian K Faria, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1120 Campbell St, Baker City, OR 97814 Phone: 541-523-2850 | |
Tyson K Barnes, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1217 Campbell St, Baker City, OR 97814 Phone: 541-523-2138 |